Jan 22, 2021
In the summer of 2019, the Institute for Clinical and Economic Review (ICER) hosted a public meeting to discuss its value assessments of new treatments for Duchenne muscular dystrophy. For patient advocates and others who follow ICER, the events of that day have...
Oct 1, 2020
As we enter the final stretch of the 2020 election season, many of us may be reviewing the candidates’ stances on issues of not only personal, but also national, importance as we consider the choices before us. High on this list for many Americans is access to...
Sep 23, 2019
A controversial healthcare formula that is frequently used to deny patients care and boost insurance profits could soon be banned in Massachusetts. Three Massachusetts state representatives, Angelo J. Puppolo, Jr., José F. Tosado and Bud L. Williams, have introduced...
Jul 11, 2019
You’ve probably never heard of it, but the Institute for Clinical and Economic Review is one of the most powerful players in healthcare. It works with insurance companies to evaluate healthcare using a math formula. By reducing every patient to a dollar amount,...
Jun 19, 2019
Since its inception, the Institute for Clinical and Economic Review has faced relentless criticism for its discriminatory health care assessments. Now, the organization is embarking on a review of its own process. Politico reports that “a coalition of 38 patient and...
